Physician profile
Kenneth D Blake
NPI 1174622070
$5,935.51
in general payments reported to CMS, 2019-2025
22 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $725 · 2020: $687 · 2021: $1,744 · 2022: $716 · 2023: $623 · 2024: $1,089 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,063.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,225.75 | 2019-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $1,340.00 | 2020-2021 | |
| Axonics, INC. | $612.03 | 2024 | Bulkamid, Axonics |
| Medtronic, INC. | $411.83 | 2022-2024 | Interstim, Ligasure |
| Davol INC. | $343.61 | 2023-2025 | Phasix Mesh, Arista, Arista Ah Flexitip |
| Aroa Biosurgery Incorporated | $317.43 | 2022-2024 | |
| Mimedx Group, INC. | $132.02 | 2025 | |
| Erbe USA INC | $109.33 | 2019-2022 | |
| Integra Lifesciences Corporation | $76.97 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Boston Scientific Corporation | $68.90 | 2019-2025 | General - Therapies |
| Tempus Ai, INC | $38.35 | 2024 | |
| Monaghan Medical Corporation | $38.12 | 2023 | Aerobika, Aerochamber |
| Ethicon US, LLC | $37.36 | 2019 | |
| Activ Surgical, INC. | $34.05 | 2024 | Activsight |
| Kerecis Limited | $29.19 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $24.13 | 2019 | |
| Innovation Technologies INC | $19.33 | 2024 | Irrisept |
| Covidien LP | $18.05 | 2019 | |
| Merck Sharp & Dohme LLC | $17.00 | 2020 | |
| Northgate Technologies, INC. | $15.46 | 2023 | Nti Branded Other (Nti) |
| Smith+Nephew, INC. | $14.87 | 2024 | Versajet |
| Melinta Therapeutics, LLC | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Blake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.